Image
Figure Caption

Figure 3—figure supplement 1.

Inhibiting hemodynamic flow leads to reduced cardiac Klf2a and Notch signaling.

( A–D) Confocal imaging performed on  klf2a:H2B-GFP ; vmhc:mCherry-NTR uninjured hearts at 24 hpt (6 dpf) reveals decreased  klf2a:H2B-GFP expression in ( B) blebbistatin (Blebb) and ( C) tricaine (Tric) treated hearts as well as in ( Dgata2a-/- mutant hearts when compared to ( A) ethanol (EtOH)-treated control hearts (n = 12 control EtOh; 6 control Blebb; 7 control Tric; 9 control  gata2a-/-). ( E–H) Confocal imaging performed on  Tp1:d2GFP ; vmhc:mCherry-NTR uninjured hearts at 24 hpt (6 dpf) shows decreased  Tp1:d2GFP Notch reporter expression in hearts treated with ( F) blebbistatin or ( G) tricaine when compared to ( E) ethanol-treated control hearts; however, ( Hgata2a-/-hearts do not display significant changes as quantitatively assessed in  Figure 3N(n = 12 control EtOh; 5 control Blebb; 7 control Tric; 9 control  gata2a-/-). ( I–L) Whole-mount in situ hybridizations reveal decreased  notch1b expression in hearts treated with ( J) blebbistatin (n = 0/9) or ( K) tricaine (n = 0/5) and in ( Lgata2a-/- hearts (n = 4/12) when compared to ( I) ethanol-treated control hearts (n = 10/10) at 24 hpt (6 dpf). All confocal images shown are maximum intensity projections. V, ventricle; A, atrium; dpf, days post-fertilization; hpt, hours post-DMSO treatment. Dashed lines outline the heart. Bars: 50 μm.

Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Elife